Effectiveness of mRNA Booster Vaccine Against Coronavirus Disease 2019 Infection and Severe Outcomes Among Persons With and Without Immune Dysfunction: A Retrospective Cohort Study of National Electronic Medical Record Data in the United States.
Jing SunQulu ZhengAlfred J AnzaloneAlison G AbrahamAmy L OlexYifan ZhangJomol MathewNasia SafdarMelissa A HaendelDorry SegevJessica Yasmine IslamJasvinder A SinghRoslyn B MannonChristopher G ChuteRena C PatelGregory D KirkPublished in: Open forum infectious diseases (2024)
Booster vaccines remain effective against severe COVID-19 BTI throughout the Delta- and Omicron-predominant periods, regardless of patients' immune status.
Keyphrases
- coronavirus disease
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- sars cov
- randomized controlled trial
- early onset
- systematic review
- electronic health record
- quality improvement
- respiratory syndrome coronavirus
- patient reported outcomes
- big data
- machine learning
- artificial intelligence
- binding protein
- deep learning